Back to Journals » International Journal of Nanomedicine » Volume 6

The use of nanocrystalline cellulose for the binding and controlled release of drugs

Authors Jackson, Letchford, Wasserman B, Ye, Hamad W, Burt H

Published 10 February 2011 Volume 2011:6 Pages 321—330


Review by Single anonymous peer review

Peer reviewer comments 2

John K Jackson1, Kevin Letchford1, Benjamin Z Wasserman1, Lucy Ye1, Wadood Y Hamad2, Helen M Burt1
1Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC, Canada; 2FPInnovations, 3800 Wesbrook Mall, Vancouver, BC, Canada

Abstract: The objective of this work was to investigate the use of nanocrystalline cellulose (NCC) as a drug delivery excipient. NCC crystallites, prepared by an acid hydrolysis method, were shown to have nanoscopic dimensions and exhibit a high degree of crystallinity. These crystallites bound significant quantities of the water soluble, ionizable drugs tetratcycline and doxorubicin, which were released rapidly over a 1-day period. Cetyl trimethylammonium bromide (CTAB) was bound to the surface of NCC and increased the zeta potential in a concentration-dependent manner from -55 to 0 mV. NCC crystallites with CTAB-modified surfaces bound significant quantities of the hydrophobic anticancer drugs docetaxel, paclitaxel, and etoposide. These drugs were released in a controlled manner over a 2-day period. The NCC-CTAB complexes were found to bind to KU-7 cells, and evidence of cellular uptake was observed.

Keywords: drug delivery, nanocrystalline cellulose, controlled release

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.